Article info
PDFReview
Imaging in low-grade glioma: a guide for neurologists
- Correspondence to Dr Fiona M McKevitt, Department of Neurology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals Foundation Trust, Sheffield, S10 2JF, UK; fionamckevitt{at}sth.nhs.uk
Citation
Imaging in low-grade glioma: a guide for neurologists
Publication history
- Accepted October 18, 2017
- First published December 5, 2017.
Online issue publication
April 19, 2018
Article Versions
- Previous version (16 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Contemporary management of low-grade glioma: a paradigm shift in neuro-oncology
- Neuro-oncology
- Advances in the management of glioblastoma
- Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy
- [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
- Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement
- Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma
- Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme
- Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution
- Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours